当前位置: 首页 > 期刊 > 《上海医药》 > 202015
编号:13840691
临床药师参与1例妊娠期糖尿病酮症酸中毒患者的药学监护(3)
http://www.100md.com 2020年5月25日 《上海医药》 202015
     [2] Peterson C, Grosse SD, Li R, et al. Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States[J]. Am J Obstet Gynecol, 2015, 212(1): 74.e1-74.e9.

    [3] 中華医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南[J]. 中华妇产科杂志, 2014, 49(8): 561-569.

    [4] ACOG Practice Bulletin No. 190 Summary: Gestational Diabetes Mellitus[J]. Obstet Gynecol, 2018, 131(2): 406-408.

    [5] 刘剑波. 妊娠糖尿病合并酮症酸中毒的临床分析及治疗效果的观察[J]. 中华全科医学, 2014, 12(1): 95-96.

    [6] Shubrook JH Jr. Insulin therapy for challenging patient cases[J]. J Am Osteopath, 2013, 113(4 Suppl 2): 217-228.

    [7] Dalfrà MG, Burlina S, Sartore G, et al. Ketoacidosis in diabetic pregnancy[J]. J Matern Fetal Neonatal Med, 2016, 29(17): 2889-2895.

    [8] Bryant SN, Herrera CL, Nelson DB, et al. Diabetic ketoacidosis complicating pregnancy[J]. J Neonatal Perinatal Med, 2017, 10(1): 17-23.

    [9] Himuro H, Sugiyama T, Nishigori H, et al. A case of a woman with late-pregnancy-onset DKA who had normal glucose tolerance in the first trimester[J/OL]. Endocrinol Diabetes Metab Case Rep, 2014, 2014: 130085. doi: 10.1530/EDM-13-0085., 百拇医药(吴文雅 王先利)
上一页1 2 3